Hormonal Treatment for Male-Pattern Hair Loss: Implications for Cancer of the Prostate
October 2002
in “
BJUI
”
TLDR Finasteride treats hair loss but may affect prostate cancer detection.
This article discusses the use of finasteride for male-pattern hair loss (MPHL) and its potential implications for prostate cancer. While finasteride has been shown to be effective in treating MPHL, there are concerns about its effects on prostate-specific antigen (PSA) levels and the potential for masking the detection of prostate cancer. Further research is needed to fully understand the relationship between hormonal treatments for hair loss and prostate cancer.